Scanview System
510(k) K110345
Scanview System is a medical device (FDA Class II; FDA product code NTH) made by Applied Spectral Imaging, cleared under FDA 510(k) K110345 on 19 Oct 2011, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK110345 | Date19 Oct 2011 | StatusActive |
Official records
- FDA 510(k) database K110345
From the FDA record
- Received by the FDA
- 4 Feb 2011
- FDA decision
- 19 Oct 2011 (Substantially Equivalent)
- FDA review time
- 257 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- NTH
- Device class
- Class II
- Regulation
- 21 CFR Part 866.4700
- Advisory committee
- Immunology
- FDA decision
- SESE Substantially Equivalent
Devices cleared under K110345
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| ASI IVD System GenASIs 8.3 | GenASIs 8.3 | 07290016630039 | On the market | |
| GenASIs™ System | GenASIs | 07290016630015 | No longer on the market | |
| GenASIs™ System | GenASIs | 07290016630008 | No longer on the market |
Similar devices
Other devices filed under FDA product code NTH (System, Automated Scanning Microscope And Image Analysis For Fluorescence In Situ Hybridization (Fish) Assays).
- ARIOL HER-2/NEU FISH by Applied Imaging Corp.
- VYSIS AUTOVYSION SYSTEM by Vysis
- CYTOVISION FOR CEP XY by Applied Imaging Corp.
- SCANVIEW HER2/NEU FISH SYSTEM by Applied Spectral Imaging Ltd
- Duet System by BioView Ltd.
- GENASIS SCANVIEW SYSTEM by Applied Spectral Imaging Ltd
- ICONOSCOPE ONCOFISH HER2 TEST SYSTEM, MODEL 2000 by Ikonisys, Inc.